Drug class
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
Mechanism of action
Chloride Channel Activation Potentiators [MoA]
General use cases
- Cystic Fibrosis
- cystic fibrosis (CF) in patients aged 1 year and older who are homozygous for the F508del mutation in the CFTR gene
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
